Bank Of America Corp Chembio Diagnostics, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.2 - $0.33 $17 - $28	86 New	86 $0
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $100 - $188	-153 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$1.09 - $2.55 $166 - $390	153 New	153 $0
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $10,223 - $26,502	-4,963 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$2.88 - $5.64 $14,293 - $27,991	4,963 New	4,963 $15,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.